Results 171 to 180 of about 79,145 (303)
ABSTRACT This patient is a 77‐year‐old male with non‐ischemic cardiomyopathy, severe tricuspid regurgitation, and moderate mitral regurgitation who underwent simultaneous transcatheter edge‐to‐edge repair of both mitral and tricuspid valves. Post‐procedure, the patient exhibited significant symptomatic improvement and reduced regurgitation severity ...
Omar Khan, Matthew Summers
wiley +1 more source
Cholinesterase activity of left and right atria of the rabbit's heart [PDF]
openaire +2 more sources
ABSTRACT Paravalvular leak (PVL) is a recognized complication after surgical mitral valve replacement and may cause heart failure, pulmonary hypertension, or hemolysis when moderate or severe. Although redo surgery is the definitive treatment, it carries substantial risk in elderly patients or those with multiple prior cardiac surgeries.
Marco Garaventa +3 more
wiley +1 more source
A rare case report of dextrocardia combined with atrial fibrillation and ischemic bowel disease. [PDF]
Zhao Y, Li J, Guo Z, Zhang X.
europepmc +1 more source
Third Degree Atrioventricular Block [PDF]
Ginter, James F., Loftis, Patrick
core +1 more source
Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]
Al-Khatib, SM +15 more
core +1 more source
Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid +4 more
wiley +1 more source
Recurrent atrial fibrillation and stroke in a young adult with congenital heart defects: A case report. [PDF]
Altell K +8 more
europepmc +1 more source
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu +9 more
wiley +1 more source

